Trials / Terminated
TerminatedNCT04397029
Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography
Assessing the Sensitivity of "SureTouch™" in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 213 (actual)
- Sponsor
- George Washington University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.
Detailed description
This is a single-center, prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity. Results of the mammography will be compared to the SureTouch examination results. Subjects will have between 1 and 3 research visits and 3 follow-up surveys, up to two years from the initial visit. The number of visits will be based upon comparison of the SureTouch examination to conventional breast screening techniques (mammogram and ultrasound).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SureTouch | The first group will consist of 70 women who are believed to be free of masses, recruited during a screening mammography appointment. The second group will include 125 women presenting for diagnostic mammography and/or biopsy appointment with known masses identified on mammogram, ultrasound or both. Both groups will receive breast cancer screening with mammography and SureTouch. |
Timeline
- Start date
- 2019-01-04
- Primary completion
- 2021-02-10
- Completion
- 2021-02-10
- First posted
- 2020-05-21
- Last updated
- 2022-06-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04397029. Inclusion in this directory is not an endorsement.